433 related articles for article (PubMed ID: 17631184)
21. Immune reconstitution after haematopoietic stem cell transplantation: obstacles and anticipated progress.
Cavazzana-Calvo M; André-Schmutz I; Dal Cortivo L; Neven B; Hacein-Bey-Abina S; Fischer A
Curr Opin Immunol; 2009 Oct; 21(5):544-8. PubMed ID: 19766472
[TBL] [Abstract][Full Text] [Related]
22. Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance.
Kline J; Subbiah S; Lazarus HM; van Besien K
Bone Marrow Transplant; 2008 Mar; 41(6):505-13. PubMed ID: 18026144
[TBL] [Abstract][Full Text] [Related]
23. [Effect of donor CD4+CD25+ regulatory T cells on hematopoietic and immune reconstitution, GVHD and disease-free survival after allogeneic hematopoietic stem cell transplantation].
Yang K; Fan ZP; Liu QF; Zhang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):537-41. PubMed ID: 18495584
[TBL] [Abstract][Full Text] [Related]
24. Hematopoietic growth factors in cancer chemotherapy.
Crawford J; Foote M; Morstyn G
Cancer Chemother Biol Response Modif; 1999; 18():250-67. PubMed ID: 10800487
[TBL] [Abstract][Full Text] [Related]
25. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
Tian Y; Deng YB; Huang YJ; Wang Y
Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
[TBL] [Abstract][Full Text] [Related]
26. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
[TBL] [Abstract][Full Text] [Related]
28. Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.
Giebel S; Nowak I; Dziaczkowska J; Czerw T; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Holowiecka-Goral A; Markiewicz M; Kopera M; Karolczyk A; Kyrcz-Krzemien S; Kusnierczyk P
Eur J Haematol; 2009 Oct; 83(4):343-56. PubMed ID: 19500138
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
[TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
31. Thymopoiesis following allogeneic stem cell transplantation: new possibilities for improvement.
Wils EJ; Cornelissen JJ
Blood Rev; 2005 Mar; 19(2):89-98. PubMed ID: 15603912
[TBL] [Abstract][Full Text] [Related]
32. Biological advances in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Duran-Struuck R; Reddy P
Transplantation; 2008 Feb; 85(3):303-8. PubMed ID: 18301323
[TBL] [Abstract][Full Text] [Related]
33. Immune restoration following hematopoietic stem cell transplantation: an evolving target.
Auletta JJ; Lazarus HM
Bone Marrow Transplant; 2005 May; 35(9):835-57. PubMed ID: 15778723
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor and activin-a serum levels following allogeneic hematopoietic stem cell transplantation.
Nachbaur D; Schumacher P; Auberger J; Clausen J; Kircher B
Biol Blood Marrow Transplant; 2007 Aug; 13(8):942-7. PubMed ID: 17640598
[TBL] [Abstract][Full Text] [Related]
35. Granulocyte-Macrophage Colony-Stimulating Factor in Allogenic Hematopoietic Stem Cell Transplantation: From Graft-versus-Host Disease to the Graft-versus-Tumor Effect.
Bernardi C; Charvet C; Zeiser R; Simonetta F
Transplant Cell Ther; 2024 Apr; 30(4):386-395. PubMed ID: 38224950
[TBL] [Abstract][Full Text] [Related]
36. Hematopoietic growth factors for the treatment of inherited cytopenias.
Zeidler C; Welte K
Semin Hematol; 2007 Jul; 44(3):133-7. PubMed ID: 17631177
[TBL] [Abstract][Full Text] [Related]
37. The therapeutic use of hematopoietic growth factors.
Costa JJ
J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):1-6. PubMed ID: 9449493
[No Abstract] [Full Text] [Related]
38. Management of infections complicating allogeneic hematopoietic stem cell transplantation.
Hiemenz JW
Semin Hematol; 2009 Jul; 46(3):289-312. PubMed ID: 19549581
[TBL] [Abstract][Full Text] [Related]
39. [Autologous transplantation of hematopoietic stem cells and growth factors].
Harousseau JL
Pathol Biol (Paris); 1993 Jan; 41(1):50. PubMed ID: 7686287
[No Abstract] [Full Text] [Related]
40. Recent progress in allogeneic stem cell transplantation.
Mattsson J
Curr Opin Mol Ther; 2008 Aug; 10(4):343-9. PubMed ID: 18683098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
